Shuifang Xiao

ORCID: 0000-0003-1554-9859
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Tracheal and airway disorders
  • Head and Neck Cancer Studies
  • Voice and Speech Disorders
  • Cancer Diagnosis and Treatment
  • Obstructive Sleep Apnea Research
  • Respiratory and Cough-Related Research
  • Dysphagia Assessment and Management
  • Head and Neck Surgical Oncology
  • Head and Neck Anomalies
  • Pediatric health and respiratory diseases
  • Ear Surgery and Otitis Media
  • Gastroesophageal reflux and treatments
  • Sinusitis and nasal conditions
  • Ear and Head Tumors
  • Allergic Rhinitis and Sensitization
  • Otolaryngology and Infectious Diseases
  • Teratomas and Epidermoid Cysts
  • Reconstructive Surgery and Microvascular Techniques
  • Cleft Lip and Palate Research
  • Salivary Gland Tumors Diagnosis and Treatment
  • Airway Management and Intubation Techniques
  • Intracranial Aneurysms: Treatment and Complications
  • Otitis Media and Relapsing Polychondritis
  • Cerebrovascular and Carotid Artery Diseases
  • Esophageal Cancer Research and Treatment

Peking University First Hospital
2015-2024

Peking University
2015-2024

Air Force General Hospital PLA
2024

People's Liberation Army Air Force
2024

GTx (United States)
2020

King University
2019

First Affiliated Hospital of Zhengzhou University
2015

Yahoo (United Kingdom)
2009

The aims of this study were to evaluate the expression enhanced green fluorescent protein (EGFP) driven by 6 different promoters, including cytomegalovirus IE enhancer and chicken β-actin promoter (CAG), (CMV), neuron-specific enolase (NSE), myosin 7A (Myo), elongation factor 1α (EF-1α), Rous sarcoma virus (RSV), assess dose response CAG transgene in cochlea. Serotype 1 adeno-associated (AAV1) vectors with various constructs transduced into cochleae, level EGFP was examined. We found highest...

10.1038/emm.2007.19 article EN cc-by Experimental & Molecular Medicine 2007-04-01

To investigate the feasibility of an endoscopic-assisted postauricular-groove approach parotidectomy and to evaluate advantages limitations such approach.A total 72 patients with parotid gland tumors underwent a procedure between January 2014 2016. Of aforementioned patients, 15 were treated by (group I), whereas remaining 57 Blair "S" incision II).Difference in visual analogue scale score for aesthetic outcome (0 vs 3) median intraoperative blood loss (30 50 mL) was statistically...

10.1002/hed.25720 article EN Head & Neck 2019-03-14

Purpose . To evaluate the value of Brodsky tonsil scale in predicting objective volume and to identify potential factors that might interfere with accuracy prediction. Methods A total 87 adult patients who underwent single tonsillectomy or uvulopalatopharyngoplasty (UPPP) procedure including our hospital between Jan 2015 Dec 2016 were included. The data evaluated preoperatively postoperatively collected for analysis. Results Among included, 85 bilateral tonsillectomy, while only 2 unilateral...

10.1155/2018/6434872 article EN cc-by BioMed Research International 2018-10-24

Abstract Background Intranasal corticosteroids are the most efficacious anti-inflammatory medications for allergic rhinitis (AR). However, efficacy and safety of intranasal in children have not yet been subject to specific research China. The aim this study was investigate fluticasone furoate nasal spray (FFNS) a Chinese pediatric population. Methods In phase 4 randomized, double-blind, placebo-controlled, multicenter study, AR patients aged 2–12 years were randomized 1:1:1, receiving either...

10.1038/s41390-020-01180-0 article EN cc-by Pediatric Research 2020-10-02

Nasopharyngeal carcinoma (NPC) is a malignant tumor which commonly found in East Asia and Africa. The present clinical treatment of NPC still mainly based on chemotherapeutics prone to drug resistance adverse reactions. Shikonin has been demonstrated play the antitumor effect various cancers. However, specific effects related regulatory mechanism have not clearly declared yet. Cell viability was valued through 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, cell...

10.1097/cad.0000000000000920 article EN Anti-Cancer Drugs 2020-04-08

Conservative treatments are usually the preferred choices for newly diagnosed adult otitis media with effusion (OME). This study was performed to explore efficacy of conservative treatments, including medication and eustachian tube auto-inflation (ETA), treating OME in adults analyze its predictors.A total 107 patients were included. All completed two weeks alone or combination ETA.The numbers only one both ears affected 79 28, respectively, therefore, 135 After treatment, 75 classified as...

10.5152/iao.2020.8091 article EN cc-by-nc The Journal of International Advanced Otology 2020-07-29

Ear molding is a safe and effective way to treat babies born with ear deformities. In this study, the authors explored long-term effectiveness of determined factors that relate recurrence.A retrospective review 200 consecutive infants treated EarWell System from March 2018 August 2019 was performed. Immediate evaluated compared.A total 190 children (314 ears) were included. The mean age at presentation 16.2 days (range, 0 100 days). most common deformity constricted [172 ears (54.8...

10.1097/prs.0000000000008293 article EN Plastic & Reconstructive Surgery 2021-08-24

Conclusion: Moxifloxacin was generally well tolerated and highly effective in the treatment of acute bacterial rhinosinusitis (ABS). The incidence adverse events (AEs) drug reactions (ADRs) low. effectiveness, safety, tolerability information collected this study confirm clinical safety profile moxifloxacin its benefit as a option for ABS. Objective: To assess under daily life conditions patients with Methods: carried out China between September 2005 May 2007. Patients ABS were treated...

10.3109/00016481003629036 article EN Acta Oto-Laryngologica 2010-03-17

Recent studies have reported the crucial role of stanniocalcin-2 (STC2) in hepatocellular carcinoma; however, its head and neck squamous cell carcinoma (HNSCC) remains elusive. In this study, microRNA-206 (miR-206) was predicted to target STC2 gene. The study herein aimed elucidate effect miR-206 on HNSCC by targeting STC2. highly expressed tissues cells. By STC2, decreased mRNA protein expression Importantly, our showed that blocked Akt signaling pathway inhibiting Intriguingly, data from...

10.1089/hum.2020.090 article EN Human Gene Therapy 2020-09-09

Objective This study aimed to evaluate knowledge of laryngopharyngeal reflux disease (LPRD) among otolaryngologists in 3A hospitals Beijing. Methods A cross-sectional questionnaire survey LPRD was conducted with 40 response rate <80% obtained from one hospital, so data 331 valid questionnaires the other 39 were analysed. Results The most common source academic lectures (80.1%). commonly known risk factors, symptoms, clinical signs and associated diseases unhealthy eating habits (49.2%),...

10.1177/0300060519888311 article EN cc-by-nc Journal of International Medical Research 2019-11-27

Introduction Renal calculi are the predominant urological ailment in air force pilots. Flexible ureteroscopy (FURS) constitutes a valuable approach for renal treatment. This study presents decade-long exploration of using FURS treatment Additionally, it investigates safety and feasibility granting waiver flights to pilots with parenchyma calcification. Methods From December 2009 2019, retrospective review was conducted on Chinese undergoing calculi. Among assessed, total 71 individuals...

10.1136/military-2024-002712 article EN BMJ Military Health 2024-06-12

MP-AzeFlu (Dymista; Meda Pharma GmbH & Co., KG), a formulation combining azelastine hydrochloride and fluticasone propionate in single spray, is superior to alone relieving symptoms improving the quality of life patients with allergic rhinitis. In this study, we evaluated whether effect AzeFlu, generic drug manufactured from China, equivalent that MP-AzeFlu. total, 679 were recruited for multicentre, randomized, double-blind, original drug-controlled, parallel-group clinical trial. Overall,...

10.5415/apallergy.0000000000000161 article EN Asia Pacific Allergy 2024-10-29
Coming Soon ...